Knowledge Center

Patent / Jan 11, 2024

Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation

Authors:
  • Beatriz Fernandes
  • Filipe Vultos
  • Eunice Costa
Source:
WO 2024009079 A1

The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.

Ìý

Also in the Knowledge Center

Related Content

Drug Product Development

Leveraging our expertise particle engineering, ËÄÉ«AV can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more

Drug Substance Technologies

We constantly innovate to find better, more efficient ways of doing things.

Page
Read more

Process Safety

Process safety is a blend of engineering and management skills that focuses on the prevention of events impacting safety, environmental damage and business losses.

Page
Read more